Clinical trial
ReDS-guided Decongestion Strategy in Patients Hospitalized for Heart Failure: the ReDS-SAFE HF II Trial
NCT07484009 is registered in ClinicalTrials.gov with Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ReDS-guided Decongestion Strategy in Patients Hospitalized for Heart Failure: the ReDS-SAFE HF II Trial
- Lead sponsor
- Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- January 29, 2026
- Completion date
- August 31, 2027
- Enrollment
- 1,014 (estimated)
- Sites
- 25
Conditions
As the registry lists them; a condition with its own page is linked.
acute heart failure (ahf), heart failure (for example, fluid overload), heart failure hospitalization